New drug shows promise against Hard-to-Treat digestive cancers
NCT ID NCT05628857
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This study tested an experimental drug called RC108 in 29 adults with advanced digestive system cancers that have a specific protein (c-Met). The goal was to see if the drug could shrink tumors or stop them from growing. Researchers also monitored side effects. The study is complete, and results will help decide if further testing is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIGESTIVE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Cancer Hopspital
Beijing, Beijing Municipality, 000000, China
Conditions
Explore the condition pages connected to this study.